← Browse by Condition
Medical Condition
brain metastases
Total Trials
16
Recruiting Now
16
Trial Phases
Phase 1, Phase 2, Phase 2, Phase 1
NCT06476093
Recruiting
SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer
Enrollment
46 pts
Location
China
Sponsor
The First People's Hospital of...
NCT06194929 Phase 1, Phase 2
Recruiting
Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma
Enrollment
33 pts
Location
United States
Sponsor
University of Utah
NCT06466720
Recruiting
Measuring and Mapping Cognitive Decline After Brain Radiosurgery
Enrollment
80 pts
Location
United Kingdom
Sponsor
University of Nottingham
NCT05064280 Phase 2
Recruiting
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
Enrollment
104 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06992973
Recruiting
Efficacy of the Association of Fractionated SRS and Subsequent Surgery in Patients With Brain Metastases
Enrollment
98 pts
Location
Italy
Sponsor
Regina Elena Cancer Institute
NCT04923542 Phase 1, Phase 2
Recruiting
Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases
Enrollment
31 pts
Location
United States
Sponsor
H. Lee Moffitt Cancer Center a...
NCT05452005 Phase 1
Recruiting
Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer
Enrollment
20 pts
Location
United States
Sponsor
University of California, Davi...
NCT07044557
Recruiting
MeDex: No Perioperative Dexamethasone in Brain Metastases
Enrollment
35 pts
Location
United States
Sponsor
University of Louisville
NCT02504788
Recruiting
A Prospective Study of the Impact of Hippocampal Avoidance During Whole Brain Radiotherapy on Neurocognitive Function Decline
Enrollment
100 pts
Location
Taiwan
Sponsor
Chang Gung Memorial Hospital
NCT03726359 Phase 1
Recruiting
Phase I Study of Fractionated Stereotactic Radiation Therapy
Enrollment
43 pts
Location
United States
Sponsor
Albert Einstein College of Med...
NCT04833335
Recruiting
ASL in Brain Metastasis MRI Following Gamma Knife Treatment
Enrollment
60 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT04073966
Recruiting
MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets
Enrollment
15 pts
Location
United States
Sponsor
UNC Lineberger Comprehensive C...
NCT06793332 Phase 2
Recruiting
BrAin Metastasis in TripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC
Enrollment
39 pts
Location
China
Sponsor
Fudan University
NCT06702826 Phase 2
Recruiting
Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases
Enrollment
20 pts
Location
China
Sponsor
Rongrong Zhou
NCT05045950 Phase 2
Recruiting
Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique
Enrollment
53 pts
Location
United States
Sponsor
Medical College of Wisconsin
NCT05535413 Phase 1, Phase 2
Recruiting
UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases
Enrollment
30 pts
Location
China
Sponsor
Hunan Cancer Hospital